BACCR

Blue Acquisition Corp. Rights represent securities issued alongside common stock during the SPAC's initial public offering, granting holders contractual abilities to purchase additional common shares at predetermined prices under specific conditions outlined in right agreements and offering documents. Each right typically allows purchasing fractional common shares often one-tenth or one-twentieth share per right at nominal exercise prices, with rights becoming exercisable upon business combination completion or other triggering events. Rights provide investors with modest additional upside participation if Blue Acquisition successfully merges with attractive companies and combined entity stock appreciates substantially, while limiting downside risk since rights trade separately and cost minimally compared to full share prices. The economic value of rights depends on ultimate merger terms, post-combination stock performance, and specific exercise provisions varying across SPACs. BACCR rights trade independently from Blue Acquisition common stock and warrants, allowing investors to construct precise exposure matching their views regarding merger prospects. Rights typically have shorter exercise windows than warrants and lower intrinsic value given fractional share purchase terms, making them primarily suitable for sophisticated investors seeking targeted SPAC exposure rather than broad retail investment vehicles. Rights pricing reflects complex factors including Blue Acquisition's progress identifying merger candidates with management capabilities influencing investor confidence, underlying common stock performance, time remaining until expiration or merger, and overall market sentiment toward SPAC investments.